pSivida Corp. Reports Positive Regulatory Outcome For ILUVIEN; Moves To National Phase For Marketing Authorizations In 10 More EU Countries
June 30, 2014 at 07:36 AM EDT
pSivida Corp. (NASDAQ: PSDV)(ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye ...
